MedPath

A diagnostic performance of Narrow Band Imaging followed by Lugol’s Chromoendoscopy combined with Probe-based Confocal Laser Endomicroscopy for Early Esophageal Squamous Cell Neoplasm in Patient with Head and Neck Cancers.

Not Applicable
Completed
Conditions
Patients with head and neck squamous cell carcinoma (SCC) had the highest risk of developing second primary esophageal SCC. Lugol’s chromoendoscopy (LCE) was the gold standard for esophageal squamou
Narrow Band Imaging&#44
based Confocal Laser Endomicroscopy&#44
Lugol’s chromoendoscopy&#44
probe&#45
Early Esophageal Squamous Cell Neoplasm
Registration Number
TCTR20180223004
Lead Sponsor
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
24
Inclusion Criteria

The inclusion criteria were age older than 18 and no dysphagia symptom.

Exclusion Criteria

The exclusion criteria were a history of nasopharyngeal squamous cell carcinoma esophageal surgery, esophageal stricture or obstruction, esophageal varices, known cases of esophageal cancer, uncorrectable coagulopathy and thrombocytopenia, pregnancy, thyrotoxicosis, creatinine clearance less than 30 mL/min, and a history of allergy to iodine and fluorescein.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
performance of dNBI for second primary ESCN diagnosis in patients with head and neck cancer at diagnosis esophagogastroduodenoscopy
Secondary Outcome Measures
NameTimeMethod
performance of LCE and pCLE for second primary ESCN diagnosis in patients with head and neck cancer at diagnosis esophagogastroduodenoscopy
© Copyright 2025. All Rights Reserved by MedPath